Medicure Net Income Over Time
| MPH Stock | CAD 1.12 0.02 1.75% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medicure Performance and Medicure Correlation. Medicure |
Cross Equities Net Income Analysis
Compare Medicure and related stocks such as DRI Healthcare Trust, HLS Therapeutics, and Cipher Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HLS | 6.9 M | 12 M | 16.9 M | 9.7 M | 12.7 M | (1.7 M) | (874.9 K) | (6.1 M) | (24.8 M) | (19.6 M) | (15.3 M) | (13.1 M) | (23.6 M) | (27.5 M) | (19.7 M) | (17.7 M) | (16.8 M) |
| CPH | (9.9 M) | (2.3 M) | 2.6 M | 23.4 M | (4.8 M) | 1.8 M | (39.1 M) | 4.4 M | 543 K | 3.2 M | 4.5 M | 7.8 M | 26.6 M | 20.4 M | 11.5 M | 13.3 M | 13.9 M |
| OGI | (140.2 K) | (140.2 K) | (375.2 K) | (239 K) | (1.3 M) | 846.7 K | (10.9 M) | 20.5 M | (9.5 M) | (136.2 M) | (130.7 M) | (14.3 M) | (229.5 M) | (45.4 M) | (24.8 M) | (22.3 M) | (23.4 M) |
| AQST | (8.3 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (8.9 M) | (61.4 M) | (66.2 M) | (55.8 M) | (70.5 M) | (54.4 M) | (7.9 M) | (44.1 M) | (39.7 M) | (41.7 M) |
| DXT | (832 K) | (832 K) | (832 K) | (832 K) | (832 K) | (832 K) | (20.3 M) | (7.8 M) | (8.2 M) | 9 M | 64 M | 24.4 M | 3.4 M | 26.6 M | 19.9 M | 22.9 M | 12.1 M |
| ERE-UN | (61.3 K) | (61.3 K) | (61.3 K) | (61.3 K) | (61.3 K) | (61.3 K) | (61.3 K) | (1.4 M) | 5.3 M | (16.8 M) | 118.7 M | 96.1 M | 116.4 M | (114.2 M) | (64.3 M) | (70.5 M) | (67 M) |
Medicure and related stocks such as DRI Healthcare Trust, HLS Therapeutics, and Cipher Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Medicure financial statement analysis. It represents the amount of money remaining after all of Medicure operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Medicure | MPH |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 2-1250 Waverley Street, |
| Exchange | TSX Venture Exchange |
CAD 1.12
Additional Tools for Medicure Stock Analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.